Achievements
We found that rosiglitazone (one of anti-diabetic drug) activates AMPK activity, and then enhances the phosphorylation of S385 of Kir6.2, and inhibits current of KATP channel, then elevates the membrane potential of β cells, ultimately leads to stimulate insulin secretion (Diabetologia 2009; 52 (6):1112-1121). We also found that Islet neogenesis associated protein (INGAP) stimulates experimental p
Awards
1994: Best Intern Kaohsiung Medical University Chung-HO Memorial Hospital
2005: Clinical Research Award Department of Health, Republic of China
2009: Award of Reseach Grant Diabetes Associaion of Republic of China
2010: Award of Excellent Paper Eendocrine & Diabetes Association of Republic of China
2010: Young Investigator Award of 2nd ABCD forum
Loading...
9
0
20
0
false
https://orcid.org/0000-0001-9437-5847